EGFR and ovarian cancer: A number of pro-survival signaling pathways is persistently activated in human ovarian cancer, including the epidermal growth factor receptor (EGFR) and janus kinase/signal transducer and activator of transcripton 3 (JAK/STAT3) pathways [4].